Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03080389 · ClinicalTrials.gov registry record
Sensitivity of Extended Cultures in Diagnosing Urinary Tract Infections
A clinical trial, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- 16
- Enrollment target
NCT03080389: Clinical Trial study, sponsored by The Cleveland Clinic.
NCT03080389 is a clinical trial that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03080389 was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- 16 participants
- Enrollment target
Study Summary
There is some evidence to suggest standard urine cultures may not be adequate in identifying patients with low grade urinary tract infections. Therefore, there are patients with symptoms of frequency and urgency, being misdiagnosed with overactive bladder due to negative urine cultures. If this is true, could extended cultures be used to identify the false negative patients?
Primary Outcome
Extended urine cultures are more sensitive in the identification of urinary tract infections in patients with symptoms of urgency and frequency then standard cultures as measured by a positive urine extended culture.
Interventions
- PROCEDURE Extended Urine Culture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2017-07-01 |
| Est. Completion | 2018-08-01 |
Why NCT03080389 stopped before completion
NCT03080389 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Extended Urine Culture is the first listed.
NCT03080389 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03080389 about?
NCT03080389 is a clinical study titled "Sensitivity of Extended Cultures in Diagnosing Urinary Tract Infections". There is some evidence to suggest standard urine cultures may not be adequate in identifying patients with low grade urinary tract infections. Therefore, there are patients with symptoms of frequency and urgency, being misdiagnosed with overactive bladder due to negative urine cultures. If this is t...
What is the current status of trial NCT03080389?
This trial is currently terminated. The enrollment target is 16 participants. The study started on 2017-07-01. Estimated completion is 2018-08-01.
What interventions are being tested in trial NCT03080389?
The interventions under investigation include: Extended Urine Culture (PROCEDURE).
Who is sponsoring clinical trial NCT03080389?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI